These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Capillary gas chromatographic determinations of urinary bile acids and bile alcohols in CTX patients proving the ineffectivity of ursodeoxycholic acid treatment. Koopman BJ, Wolthers BG, van der Molen JC, Nagel GT, Waterreus RJ, Oosterhuis HJ. Clin Chim Acta; 1984 Sep 15; 142(1):103-11. PubMed ID: 6478619 [Abstract] [Full Text] [Related]
3. Effect of chenodeoxycholic acid on biliary and urinary bile acids and bile alcohols in cerebrotendinous xanthomatosis; monitoring by high performance liquid chromatography. Batta AK, Shefer S, Batta M, Salen G. J Lipid Res; 1985 Jun 15; 26(6):690-8. PubMed ID: 4031647 [Abstract] [Full Text] [Related]
11. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis. Salen G, Shefer S, Tint GS. Gastroenterology; 1984 Aug 31; 87(2):276-83. PubMed ID: 6735073 [Abstract] [Full Text] [Related]
12. Hydrophilic 7 beta-hydroxy bile acids, lovastatin, and cholestyramine are ineffective in the treatment of cerebrotendinous xanthomatosis. Batta AK, Salen G, Tint GS. Metabolism; 2004 May 31; 53(5):556-62. PubMed ID: 15131757 [Abstract] [Full Text] [Related]
13. Combined treatment with chenodeoxycholic acid and pravastatin improves plasma cholestanol levels associated with marked regression of tendon xanthomas in cerebrotendinous xanthomatosis. Nakamura T, Matsuzawa Y, Takemura K, Kubo M, Miki H, Tarui S. Metabolism; 1991 Jul 31; 40(7):741-6. PubMed ID: 1908036 [Abstract] [Full Text] [Related]
14. Cerebrotendinous xanthomatosis: a review of biochemical findings of the patient population in The Netherlands. Koopman BJ, Wolthers BG, van der Molen JC, van der Slik W, Waterreus RJ, van Spreeken A. J Inherit Metab Dis; 1988 Jul 31; 11(1):56-75. PubMed ID: 3128689 [Abstract] [Full Text] [Related]
15. Isotopomer spectral analysis of intermediates of cholesterol synthesis in patients with cerebrotendinous xanthomatosis. Clarenbach JJ, Lindenthal B, Dotti MT, Federico A, Kelleher JK, von Bergmann K. Metabolism; 2005 Mar 31; 54(3):335-44. PubMed ID: 15736111 [Abstract] [Full Text] [Related]
20. Occurrence of bile alcohol glucuronides in bile of patients with cerebrotendinous xanthomatosis. Hoshita T, Yasuhara M, Une M, Kibe A, Itoga E, Kito S, Kuramoto T. J Lipid Res; 1980 Nov 31; 21(8):1015-21. PubMed ID: 7462799 [Abstract] [Full Text] [Related] Page: [Next] [New Search]